Loss of inhibition over master pathways of bone mass regulation results in osteosclerotic bone metastases in prostate cancer. Swiss Med Wkly [Internet]. 2009 Apr. 18 [cited 2025 Nov. 3];139(1516):220-. Available from: https://smw.ch/index.php/smw/article/view/969